- Home
- OLMA vs FINS Comparison
OLMA vs FINS Comparison
Compare OLMA & FINS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OLMA
- FINS
- Stock Information
- Founded
- OLMA 2006
- FINS 2019
- Country
- OLMA United States
- FINS United States
- Employees
- OLMA N/A
- FINS N/A
- Industry
- OLMA Biotechnology: Pharmaceutical Preparations
- FINS Finance/Investors Services
- Sector
- OLMA Health Care
- FINS Finance
- Exchange
- OLMA Nasdaq
- FINS Nasdaq
- Market Cap
- OLMA 299.7M
- FINS N/A
- IPO Year
- OLMA 2020
- FINS N/A
- Fundamental
- Price
- OLMA $4.55
- FINS $12.98
- Analyst Decision
- OLMA Strong Buy
- FINS
- Analyst Count
- OLMA 4
- FINS 0
- Target Price
- OLMA $24.50
- FINS N/A
- AVG Volume (30 Days)
- OLMA 1.1M
- FINS 78.0K
- Earning Date
- OLMA 08-05-2025
- FINS 01-01-0001
- Dividend Yield
- OLMA N/A
- FINS 9.97%
- EPS Growth
- OLMA N/A
- FINS N/A
- EPS
- OLMA N/A
- FINS N/A
- Revenue
- OLMA N/A
- FINS N/A
- Revenue This Year
- OLMA N/A
- FINS N/A
- Revenue Next Year
- OLMA N/A
- FINS N/A
- P/E Ratio
- OLMA N/A
- FINS N/A
- Revenue Growth
- OLMA N/A
- FINS N/A
- 52 Week Low
- OLMA $2.86
- FINS $11.61
- 52 Week High
- OLMA $16.62
- FINS $12.57
- Technical
- Relative Strength Index (RSI)
- OLMA 54.89
- FINS 54.96
- Support Level
- OLMA $4.45
- FINS $12.71
- Resistance Level
- OLMA $4.80
- FINS $12.84
- Average True Range (ATR)
- OLMA 0.29
- FINS 0.13
- MACD
- OLMA 0.07
- FINS 0.02
- Stochastic Oscillator
- OLMA 85.42
- FINS 98.86
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.